Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Virucidal activity of ortho-phthalaldehyde solutions against hepatitis B and C viruses.

Roberts CG, Chan-Myers HB, Favero MS.

Am J Infect Control. 2008 Apr;36(3):223-6. doi: 10.1016/j.ajic.2007.08.005.

PMID:
18371520
2.

Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections.

Favero MS.

Infect Control Hosp Epidemiol. 2003 Oct;24(10):787. No abstract available.

PMID:
14587949
3.

Products containing biocides: perceptions and realities.

Favero MS.

Symp Ser Soc Appl Microbiol. 2002;(31):72S-77S. Review.

PMID:
12481831
4.

Products containing biocides: perceptions and realities.

Favero MS.

J Appl Microbiol. 2002;92 Suppl:72S-7S. Review.

5.

Requiem for reuse of single-use devices in US hospitals.

Favero MS.

Infect Control Hosp Epidemiol. 2001 Sep;22(9):539-41. No abstract available.

PMID:
11732781
6.

Are standards for dialysate purity in hemodialysis insufficiently strict?

Tielemans C, Hoenich NA, Levin NW, Lonnemann G, Favero MS, Schiffl H.

Semin Dial. 2001 Sep-Oct;14(5):328-36. No abstract available.

PMID:
11679098
7.

Congress approves needlestick safety bill.

Pugliese G, Favero MS.

Infect Control Hosp Epidemiol. 2000 Dec;21(12):805-6. No abstract available.

PMID:
11140919
8.

Effect of dispensers and hand antiseptic on hand hygiene.

Pugliese G, Favero MS.

Infect Control Hosp Epidemiol. 2000 Aug;21(8):495. No abstract available.

PMID:
10968712
9.

Multidose vial transmits HCV.

Pugliese G, Favero MS.

Infect Control Hosp Epidemiol. 2000 Jun;21(6):425. No abstract available.

PMID:
10879575
10.

Role of the CDC in hemodialysis: an historical perspective.

Favero MS.

Semin Dial. 2000 Mar-Apr;13(2):64-7. No abstract available.

PMID:
10795106
11.

Surveillance of unexplained illness and death.

Pugliese G, Favero MS.

Infect Control Hosp Epidemiol. 1998 Apr;19(4):285-6. No abstract available.

PMID:
9605280
12.

Postdischarge surgical-site surveillance.

Pugliese G, Favero MS.

Infect Control Hosp Epidemiol. 1998 Apr;19(4):284. No abstract available.

PMID:
9605279
13.

Progress of US hospitals in implementing TB control programs.

Pugliese G, Favero MS.

Infect Control Hosp Epidemiol. 1998 Apr;19(4):284. No abstract available.

PMID:
9605278
14.

CJD update.

Sehulster LM, Favero MS, Bond WW.

Infect Control Hosp Epidemiol. 1998 Feb;19(2):142-3. No abstract available.

PMID:
9510117
15.

EPA charges illegal claim for antibacterial-impregnated consumer products.

Pugliese G, Favero MS.

Infect Control Hosp Epidemiol. 1998 Feb;19(2):140. No abstract available.

PMID:
9510115
16.

Susceptibility of vancomycin-resistant enterococci to environmental disinfectants.

Anderson RL, Carr JH, Bond WW, Favero MS.

Infect Control Hosp Epidemiol. 1997 Mar;18(3):195-9.

PMID:
9090548
17.

National surveillance of dialysis associated diseases in the United States--1994.

Tokars JI, Alter MJ, Miller E, Moyer LA, Favero MS.

ASAIO J. 1997 Jan-Feb;43(1):108-19.

PMID:
9116344
18.

Infections transmitted by endoscopy: an international problem.

Favero MS, Pugliese G.

Am J Infect Control. 1996 Oct;24(5):343-5. No abstract available.

PMID:
8902107
19.

National surveillance of dialysis associated diseases in the United States, 1993.

Tokars JI, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA.

ASAIO J. 1996 May-Jun;42(3):219-29.

PMID:
8725695
21.
22.

APHA session features emerging infections.

Favero MS.

Emerg Infect Dis. 1995 Oct-Dec;1(4):157. No abstract available.

23.
24.

Transmission of blood-borne pathogens during sports: risk and prevention.

Mast EE, Goodman RA, Bond WW, Favero MS, Drotman DP.

Ann Intern Med. 1995 Feb 15;122(4):283-5. Review.

PMID:
7825765
25.

Potency of endotoxin from bicarbonate dialysate compared with endotoxins from Escherichia coli and Shigella flexneri.

Bland LA, Oliver JC, Arduino MJ, Oettinger CW, McAllister SK, Favero MS.

J Am Soc Nephrol. 1995 Feb;5(8):1634-7.

26.

National surveillance of dialysis associated diseases in the United States, 1992.

Tokars JI, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA.

ASAIO J. 1994 Oct-Dec;40(4):1020-31.

PMID:
7858322
27.

The effect of uremia on tumor necrosis factor-alpha release after an in vitro whole-blood endotoxin challenge.

Oettinger CW, Bland LA, Oliver JC, Arduino MJ, McAllister SK, Favero MS.

J Am Soc Nephrol. 1994 May;4(11):1890-5.

28.

Forum: disinfection & sterilization procedures used in hospitals in the U.S.

Favero MS.

Asepsis. 1994;16(4):16-9. No abstract available.

PMID:
7880502
29.

Transmission of HIV in dialysis units.

Favero MS.

ANNA J. 1993 Oct;20(5):599-600. No abstract available.

PMID:
8285803
30.

National surveillance of dialysis associated diseases in the United States, 1991.

Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA.

ASAIO J. 1993 Oct-Dec;39(4):966-75.

PMID:
8123937
31.

Is eliminating flash sterilization practical?

Favero MS, Manian FA.

Infect Control Hosp Epidemiol. 1993 Aug;14(8):479-80. No abstract available.

PMID:
8376740
32.

Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge.

Oliver JC, Bland LA, Oettinger CW, Arduino MJ, McAllister SK, Aguero SM, Favero MS.

Lymphokine Cytokine Res. 1993 Apr;12(2):115-20.

PMID:
8324076
33.

The colonization of solid PVC surfaces and the acquisition of resistance to germicides by water micro-organisms.

Vess RW, Anderson RL, Carr JH, Bond WW, Favero MS.

J Appl Bacteriol. 1993 Feb;74(2):215-21.

PMID:
8444652
34.

National surveillance of hemodialysis associated diseases in the United States, 1990.

Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA.

ASAIO J. 1993 Jan-Mar;39(1):71-80.

PMID:
8382540
35.

Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors.

Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR.

Kidney Int. 1992 Nov;42(5):1232-7.

36.

A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin.

Pegues DA, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Gordon SM, Favero MS, Jarvis WR.

J Am Soc Nephrol. 1992 Oct;3(4):1002-7.

37.

Favero: strategies to prevent transmission differ for patients, staff.

Favero MS.

Nephrol News Issues. 1992 Oct;6(10):11. No abstract available.

PMID:
1338639
38.

Bacteria and endotoxin removal from bicarbonate dialysis fluids for use in conventional, high-efficiency, and high-flux hemodialysis.

Oliver JC, Bland LA, Oettinger CW, Arduino MJ, Garrard M, Pegues DA, McAllister S, Moone T, Aguero S, Favero MS.

Artif Organs. 1992 Apr;16(2):141-5.

PMID:
10078235
39.

Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin.

Gordon SM, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Favero MS, Jarvis WR.

J Am Soc Nephrol. 1992 Mar;2(9):1436-44.

40.

Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations.

Bland LA, Villarino ME, Arduino MJ, McAllister SK, Gordon SM, Uyeda CT, Valdon C, Potts D, Jarvis WR, Favero MS.

J Thorac Cardiovasc Surg. 1992 Mar;103(3):582-8.

PMID:
1545559
41.

Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions.

Powell AC, Bland LE, Oettinger CW, McAllister SK, Oliver JC, Arduino MJ, Favero MS.

J Am Soc Nephrol. 1991 Nov;2(5):1007-13.

42.

Enhanced release of TNF-alpha, but not IL-1 beta, from uremic blood after endotoxin stimulation.

Powell AC, Bland LA, Oettinger CW, McAllister SK, Oliver JC, Arduino MJ, Favero MS.

Lymphokine Cytokine Res. 1991 Oct;10(5):343-6.

PMID:
1768736
43.

Illness in hemodialysis patients after exposure to chloramine contaminated dialysate.

Tipple MA, Shusterman N, Bland LA, McCarthy MA, Favero MS, Arduino MJ, Reid MH, Jarvis WR.

ASAIO Trans. 1991 Oct-Dec;37(4):588-91.

PMID:
1768494
44.

Microbial growth and endotoxin production in the intravenous anesthetic propofol.

Arduino MJ, Bland LA, McAllister SK, Aguero SM, Villarino ME, McNeil MM, Jarvis WR, Favero MS.

Infect Control Hosp Epidemiol. 1991 Sep;12(9):535-9.

PMID:
1940276
45.

Effects of incubation time and temperature on microbiologic sampling procedures for hemodialysis fluids.

Arduino MJ, Bland LA, Aguero SM, Favero MS.

J Clin Microbiol. 1991 Jul;29(7):1462-5.

46.

Investigations of intrinsic Pseudomonas cepacia contamination in commercially manufactured povidone-iodine.

Anderson RL, Vess RW, Carr JH, Bond WW, Panlilio AL, Favero MS.

Infect Control Hosp Epidemiol. 1991 May;12(5):297-302.

PMID:
1865100
47.

Strategies for disinfection and sterilization of endoscopes: the gap between basic principles and actual practice.

Favero MS.

Infect Control Hosp Epidemiol. 1991 May;12(5):279-81. No abstract available.

PMID:
1865098
48.

Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis. The Cooperative Dialysis Study Group.

Marcus R, Favero MS, Banerjee S, Solomon SL, Bell DM, Jarvis WR, Martone WJ.

Am J Med. 1991 May;90(5):614-9.

PMID:
1851396
49.

National surveillance of dialysis-associated diseases in the United States, 1989.

Alter MJ, Favero MS, Moyer LA, Bland LA.

ASAIO Trans. 1991 Apr-Jun;37(2):97-109.

PMID:
1830208
50.

Comparison of microbiologic assay methods for hemodialysis fluids.

Arduino MJ, Bland LA, Aguero SM, Carson L, Ridgeway M, Favero MS.

J Clin Microbiol. 1991 Mar;29(3):592-4.

Supplemental Content

Loading ...
Support Center